PI3K/AKT/mTOR通路
自噬
程序性细胞死亡
生物
蛋白激酶B
细胞生物学
LY294002型
坏死
细胞凋亡
磷酸肌醇3激酶
基因敲除
RPTOR公司
信号转导
癌症研究
生物化学
遗传学
作者
Ya Fei Wu,Huiling Tan,Qing Huang,Choon‐Nam Ong,Han‐Ming Shen
出处
期刊:Autophagy
[Taylor & Francis]
日期:2009-08-16
卷期号:5 (6): 824-834
被引量:188
摘要
Our previous work has shown that autophagy plays a pro-survival function in two necrotic cell death models: zVAD-treated L929 cells as well as H2O2-treated Bax-/-Bak-/- mouse embryonic fibroblasts (DKO MEF). This study aims to further explore the regulatory role of autophagy in necrosis by examining the functional role of the phosphoinositide-3 kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) signaling pathway. Our initial intriguing finding was that insulin is able to promote necrotic cell death induced by zVAD and MNNG in L929 cells or by H2O2 in DKO MEF cells cultured in full growth medium. The pro-necrosis function of insulin was further supported by the observations that insulin is capable of abolishing the protective effect of starvation on necrotic cell death induced by zVAD in L929 cells. Next, we demonstrated that insulin acts on the PI3K-Akt-mTOR pathway to promote necrosis as the suppression of the above pathway by either chemical inhibitors (LY294002 and rapamycin) or mTOR knockdown is able to mitigate the pro-death function of insulin. Finally, we provided evidence that the pro-death function of insulin is dependent on its inhibitory effect on autophagy, which serves as an important pro-survival function in necrosis. Taken together, here we provide compelling evidence to show that activation of the PI3K-Akt-mTOR signaling pathway can promote necrotic cell death via suppression of autophagy, at least in the necrosis models defined in our study in which autophagy serves as a pro-survival function. Data from this study not only further underscore the pro-survival function of autophagy in necrotic cell death, but also provide a novel insight into the intricate connections linking the PI3K-Akt-mTOR signaling pathway with cell death via modulation of autophagy.
科研通智能强力驱动
Strongly Powered by AbleSci AI